靶点针对疾病信息23(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
TARGETID
T23547
TARGNAME
Opioid receptor (OPR)
INDICATI
Approved Cerebral ischaemic stroke [ICD-11: 8B11]
INDICATI
Approved Cough [ICD-11: MD12]
INDICATI
Approved Human immunodeficiency virus disease [ICD-11: 1C60-1C62]
INDICATI
Approved Opioid use disorder [ICD-11: 6C43]
INDICATI
Approved Pain [ICD-11: MG30-MG3Z]
INDICATI
Approved Sensation disturbance [ICD-11: MB40]
INDICATI
Approved Substance abuse [ICD-11: 6C40]
INDICATI
Phase 4 Chronic pain [ICD-11: MG30]
INDICATI
Phase 3 Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Phase 3 General pain disorder [ICD-11: 8E43]
INDICATI
Phase 3 Obesity [ICD-11: 5B80-5B81]
INDICATI
Phase 3 Sexual dysfunction [ICD-11: HA00-HA01]
INDICATI
Phase 2 Anxiety disorder [ICD-11: 6B00-6B0Z]
INDICATI
Phase 2 Hepatitis virus infection [ICD-11: 1E50-1E51]
INDICATI
Phase 2 Influenza [ICD-11: 1E30-1E32]
INDICATI
Preclinical Irritable bowel syndrome [ICD-11: DD91]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3